UCHealth University Of Colorado Hospital has a new antibody drug to treat high-risk COVID patients.
The hospital got 650 doses of the experimental drug bamlanivimab.
UCHealth University Of Colorado Hospital has a new antibody drug to treat high-risk COVID patients.
The hospital got 650 doses of the experimental drug bamlanivimab.
UCHealth is treating COVID-19 patients with a new experimental antibody drug that will hopefully keep the most high-risk patients..